Olopatadine {90000325}
| Parent: | [ ] |
|---|---|
| Definition: | Olopatadine |
| Queue: | [ ] |
| Initialisation date: | [ ] |
|---|---|
| Specification: | |
| [ ] | |
| Source: | |
| [ ] | |
| Structural Type: | [ ] |
|---|---|
| Functional Type: | [ ] |
| Function: | Anti-inflammatory |
Notes:
[ ]
Shared Reference Notes
- [1.1] [#Systemic lupus erythematosus]
- The SLE-enriched genera, including Bacteroides, were positively correlated with several SLE-enriched metabolites, including olopatadine. - The SLE-depleted genera, such as Pseudomonas, were negatively correlated to SLE-depleted cytokines, including interleukin-8. - Megamonas and Phocaeicola were negatively correlated with serum complement component 3, and Streptococcus was positively correlated with IgG. - [#Systemic lupus erythematosus] - Olopatadine, were more abundant in SLE patients. Olopatadine appears to have significant anti-inflammatory activity, and inhibits histamine release from mast cells. Thus, the increase of olopatadine in urine might play a potential protective role for SLE patients.
References Notes
[ ]